目的:探讨心血通胶囊对冠状动脉支架术后患者的影响。方法:选取佛山市顺德区中医院120例冠状动脉支架术后患者随机分为治疗组和对照组,各60例;对照组予西医常规治疗加安慰剂,治疗组予西医常规治疗加心血通胶囊。观察比较两组患者的中医证候积分、心绞痛再发率及不良反应。结果:在中医证候积分改善的时间方面,治疗组明显早于对照组;从治疗后3月起,治疗组的胸闷积分较对照组改善明显(P<0.05)。治疗结束后,治疗组中医证候疗效优于对照组(P<0.05),治疗组心绞痛再发率明显低于对照组(P<0.05)。两组均未见明显不良反应。结论:心血通胶囊显著改善冠状动脉支架术后患者的中医证候积分,提高中医证候疗效,减少心绞痛复发率,且安全性较好。 Objective: To investigate the effect of Xuesantong Capsule on patients after coronary stenting. Methods: A total of 120 patients with coronary stent were randomly divided into treatment group and control group, with 60 cases in each group. The control group was treated with conventional western medicine and placebo. The treatment group was treated with routine Western medicine plus XHXT capsule . The TCM syndrome scores, the recurrence rate of angina pectoris and adverse reactions in the two groups were observed and compared. Results: Compared with the control group, the treatment group was significantly earlier than the control group in terms of improving the TCM syndrome score. From March on, the chest tightness score of the treatment group improved significantly (P <0.05). After treatment, the curative effect of traditional Chinese medicine in the treatment group was better than that in the control group (P <0.05). The recurrence rate of angina in the treatment group was significantly lower than that of the control group (P <0.05). No obvious adverse reactions were found in both groups. CONCLUSION: XHXT capsule can significantly improve the TCM syndrome scores of patients after coronary stent implantation, improve the curative effect of traditional Chinese medicine and reduce the recurrence rate of angina pectoris, and have better safety.